• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分析肿瘤免疫微环境中与 N6-甲基腺苷相关的长非编码 RNA 及其在胰腺癌中的预后作用。

Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer.

机构信息

Department of Liver Transplantation and Hepatobiliary Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250021, Shandong Province, China.

Department of Liver Transplantation and Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong Province, China.

出版信息

J Cancer Res Clin Oncol. 2022 Jul;148(7):1613-1626. doi: 10.1007/s00432-022-03985-4. Epub 2022 Mar 21.

DOI:10.1007/s00432-022-03985-4
PMID:35314871
Abstract

BACKGROUND

Pancreatic cancer (PC) is a rare solid malignancy with a poor prognosis. N6-methyladenosine (m6A) and long noncoding RNAs (lncRNAs) play essential roles in tumorigenesis and progression. However, little is known about the role of m6A-related lncRNAs in PC.

METHODS

m6A-related lncRNAs were extracted by Pearson analysis, and then prognosis-related lncRNAs were filtered from the m6A-related lncRNAs by univariate Cox regression analysis. Based on the expression patterns of the prognosis-related lncRNAs, samples were classified into distinct clusters. Least absolute shrinkage and selection operator (LASSO) Cox regression was used to construct a m6A-lncRNA-related prognostic signature for PC patients. Receiver operating characteristic (ROC) curves and the corresponding area under the curve (AUC) values were used to evaluate the prognostic ability of the model.

RESULTS

A total of 178 tumor and 4 normal samples were extracted from The Cancer Genome Atlas (TCGA) database in our study. Based on the expression of 12 filtered prognosis-related lncRNAs, two distinct clusters were eventually identified; these clusters were characterized by differences in the tumor immune microenvironment (TIME) and prognosis. A risk model comprising ten m6A-related lncRNAs was identified as an independent predictor of prognosis. ROC analysis revealed that this model had an acceptable prognostic value for PC patients. The prognostic signature was related to the TIME and the expression of critical immune checkpoint molecules.

CONCLUSION

This study comprehensively assessed the expression pattern and prognostic value of m6A-related lncRNAs in PC. The different clusters correlated with distinct TIMEs and prognoses. The study also constructed a ten-gene signature prognostic model based on m6A-related lncRNAs, which showed good accuracy in predicting overall survival.

摘要

背景

胰腺癌(PC)是一种罕见的实体恶性肿瘤,预后不良。N6-甲基腺苷(m6A)和长非编码 RNA(lncRNA)在肿瘤发生和进展中发挥着重要作用。然而,关于 m6A 相关 lncRNA 在 PC 中的作用知之甚少。

方法

通过 Pearson 分析提取 m6A 相关 lncRNA,然后通过单变量 Cox 回归分析从 m6A 相关 lncRNA 中筛选预后相关 lncRNA。根据预后相关 lncRNA 的表达模式,将样本分为不同的聚类。最小绝对收缩和选择算子(LASSO)Cox 回归用于构建 PC 患者的 m6A-lncRNA 相关预后特征。接收器操作特征(ROC)曲线和相应的曲线下面积(AUC)值用于评估模型的预后能力。

结果

本研究共从癌症基因组图谱(TCGA)数据库中提取了 178 个肿瘤和 4 个正常样本。基于 12 个筛选出的预后相关 lncRNA 的表达,最终确定了两个不同的聚类;这些聚类的特点是肿瘤免疫微环境(TIME)和预后的差异。确定了一个包含十个 m6A 相关 lncRNA 的风险模型,作为预后的独立预测因子。ROC 分析表明,该模型对 PC 患者具有可接受的预后价值。该预后特征与 TIME 和关键免疫检查点分子的表达有关。

结论

本研究全面评估了 m6A 相关 lncRNA 在 PC 中的表达模式和预后价值。不同的聚类与不同的 TIME 和预后相关。该研究还构建了一个基于 m6A 相关 lncRNA 的十个基因特征预后模型,该模型在预测总生存率方面具有良好的准确性。

相似文献

1
Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer.分析肿瘤免疫微环境中与 N6-甲基腺苷相关的长非编码 RNA 及其在胰腺癌中的预后作用。
J Cancer Res Clin Oncol. 2022 Jul;148(7):1613-1626. doi: 10.1007/s00432-022-03985-4. Epub 2022 Mar 21.
2
A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.一种新型铜诱导细胞死亡相关 lncRNA 预后标志物与胃癌免疫浸润和临床价值相关。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10543-10559. doi: 10.1007/s00432-023-04916-7. Epub 2023 Jun 8.
3
Construction and validation of N6-methyladenosine long non-coding RNAs signature of prognostic value for early biochemical recurrence of prostate cancer.用于前列腺癌早期生化复发预后价值的N6-甲基腺嘌呤长链非编码RNA特征的构建与验证
J Cancer Res Clin Oncol. 2023 May;149(5):1969-1983. doi: 10.1007/s00432-022-04040-y. Epub 2022 Jun 22.
4
Systematic transcriptomic analysis of childhood medulloblastoma identifies N6-methyladenosine-dependent lncRNA signatures associated with molecular subtype, immune cell infiltration, and prognosis.系统转录组分析儿童髓母细胞瘤,确定与分子亚型、免疫细胞浸润和预后相关的 N6-甲基腺苷依赖性长非编码 RNA 特征。
Acta Neuropathol Commun. 2024 Aug 28;12(1):138. doi: 10.1186/s40478-024-01848-2.
5
Identification of N6-Methyladenosine-Associated lncRNAs and Analysis of Prognostic Signature in Breast Cancer.乳腺癌中N6-甲基腺苷相关长链非编码RNA的鉴定及预后特征分析
Biochem Genet. 2024 Jul 23. doi: 10.1007/s10528-024-10889-0.
6
LncRNAs associated with vascular mimicry establish a novel molecular subtype and prognostic model for pancreatic cancer.与血管拟态相关的长链非编码 RNA 为胰腺癌建立了一个新的分子亚型和预后模型。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11571-11584. doi: 10.1007/s00432-023-05015-3. Epub 2023 Jul 4.
7
Development and Validation of Anoiki-Related Lncrna Signature Prediction Model for KIRC Prognosis.用于肾透明细胞癌预后的anoiki相关长链非编码RNA特征预测模型的开发与验证
Comb Chem High Throughput Screen. 2025;28(9):1524-1542. doi: 10.2174/0113862073271880231114100544.
8
Expression and prognostic signatures of m6A-related lncRNAs in hepatocellular carcinoma.m6A 相关 lncRNAs 在肝细胞癌中的表达和预后特征。
J Cancer Res Clin Oncol. 2023 Jul;149(8):4429-4441. doi: 10.1007/s00432-022-04338-x. Epub 2022 Sep 19.
9
LDHA is a prognostic biomarker on the immune response in pancreatic adenocarcinoma and associated with m6A modification.LDHA 是胰腺腺癌免疫反应的预后生物标志物,并与 m6A 修饰相关。
J Cancer Res Clin Oncol. 2023 Jul;149(8):4853-4865. doi: 10.1007/s00432-022-04400-8. Epub 2022 Oct 21.
10
Construction and validation of a lipid metabolism-related genes prognostic signature for skin cutaneous melanoma.皮肤黑色素瘤脂质代谢相关基因预后特征的构建与验证
Biochem Biophys Res Commun. 2025 May 29;775:152115. doi: 10.1016/j.bbrc.2025.152115.

引用本文的文献

1
Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells.m6A甲基化修饰与非编码RNA之间的相互作用及其对肿瘤细胞的影响概述
Transl Cancer Res. 2024 Jun 30;13(6):3106-3125. doi: 10.21037/tcr-23-2401. Epub 2024 Jun 27.
2
Non-coding RNA-Mediated N6-Methyladenosine (mA) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response.非编码RNA介导的N6-甲基腺苷(m⁶A)沉积:癌症的关键调节因子,影响致癌作用和治疗反应中的关键信号通路。
Noncoding RNA Res. 2023 Nov 13;9(1):84-104. doi: 10.1016/j.ncrna.2023.11.005. eCollection 2024 Mar.
3

本文引用的文献

1
Long non-coding RNAs in brain tumors: roles and potential as therapeutic targets.脑肿瘤中的长非编码 RNA:作为治疗靶点的作用和潜力。
J Hematol Oncol. 2021 May 12;14(1):77. doi: 10.1186/s13045-021-01088-0.
2
Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N-methyladenosine of PARP1 mRNA and downregulating PTEN.TRAF3IP2-AS1 低表达通过刺激 PARP1 mRNA 的 N-甲基腺苷化和下调 PTEN 促进 NONO-TFE3 易位肾细胞癌的进展。
J Hematol Oncol. 2021 Mar 19;14(1):46. doi: 10.1186/s13045-021-01059-5.
3
lncRNA Promotes the Proliferation of Retinoblastoma Cells Through Downregulating miR34a Methylation.
RNA Modifications Meet Tumors.
RNA修饰与肿瘤相遇。
Cancer Manag Res. 2022 Nov 22;14:3223-3243. doi: 10.2147/CMAR.S391067. eCollection 2022.
长链非编码RNA通过下调miR34a甲基化促进视网膜母细胞瘤细胞增殖。
Cancer Manag Res. 2020 Dec 30;12:13461-13467. doi: 10.2147/CMAR.S268380. eCollection 2020.
4
Tumor-infiltrating B cell is associated with the control of progression of gastric cancer.肿瘤浸润性B细胞与胃癌进展的控制相关。
Immunol Res. 2021 Feb;69(1):43-52. doi: 10.1007/s12026-020-09167-z. Epub 2020 Nov 24.
5
The Potential Roles of RNA N6-Methyladenosine in Urological Tumors.RNA N6-甲基腺嘌呤在泌尿系统肿瘤中的潜在作用。
Front Cell Dev Biol. 2020 Sep 9;8:579919. doi: 10.3389/fcell.2020.579919. eCollection 2020.
6
Upregulation of METTL14 mediates the elevation of PERP mRNA N adenosine methylation promoting the growth and metastasis of pancreatic cancer.上调 METTL14 介导 PERP mRNA N6-腺苷甲基化水平升高,促进胰腺癌的生长和转移。
Mol Cancer. 2020 Aug 25;19(1):130. doi: 10.1186/s12943-020-01249-8.
7
Regulation and modulation of antitumor immunity in pancreatic cancer.胰腺癌中的抗肿瘤免疫的调控与调节。
Nat Immunol. 2020 Oct;21(10):1152-1159. doi: 10.1038/s41590-020-0761-y. Epub 2020 Aug 17.
8
Comprehensive Analysis of the PD-L1 and Immune Infiltrates of mA RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌中 mA RNA 甲基化调节剂的 PD-L1 与免疫浸润的综合分析
Mol Ther Nucleic Acids. 2020 Sep 4;21:299-314. doi: 10.1016/j.omtn.2020.06.001. Epub 2020 Jun 3.
9
Pancreatic cancer.胰腺癌。
Lancet. 2020 Jun 27;395(10242):2008-2020. doi: 10.1016/S0140-6736(20)30974-0.
10
Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx.使用 CIBERSORTx 分析批量组织中的细胞类型丰度和表达。
Methods Mol Biol. 2020;2117:135-157. doi: 10.1007/978-1-0716-0301-7_7.